e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Hospital-acquired infections: from prevention to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating levels of miR-150 and miR-126 are associated with poor outcomes of influenza A/H1N1 virus infection.
J. Zuniga (Mexico City, Mexico)
Source:
International Congress 2017 – Hospital-acquired infections: from prevention to treatment
Session:
Hospital-acquired infections: from prevention to treatment
Session type:
Oral Presentation
Number:
4654
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Zuniga (Mexico City, Mexico). Circulating levels of miR-150 and miR-126 are associated with poor outcomes of influenza A/H1N1 virus infection.. 4654
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Risk factors of fatal outcomes in influenza A/H1N1-09 viral infection
Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic
Year: 2011
Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients
Source: Annual Congress 2011 - Lung transplantation
Year: 2011
Long-term outcomes after viral pneumonia caused by influenza A (H1N1)
Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic
Year: 2011
Clarithromycin inhibits pandemic A/H1N1/2009 influenza virus infection in human airway epithelial cells
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Characteristics of patients diagnosed of influenza A virus (H1N1) infection in relation to service in charge
Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology
Year: 2010
Obesity as the most considerable risk factor for death due to influenza A/H1N1-09 viral infection
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Characteristics and outcome of pneumonia in patients with 2009 pandemic influenza A/H1N1.
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010
Predictors of H1N1 severe infection
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010
Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks
Source: Eur Respir J, 56 (3) 2001400; 10.1183/13993003.01400-2020
Year: 2020
Influenza type A outbreak associated with myositis
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1
Source: Eur Respir J 2011; 38: 739-742
Year: 2011
Endothelial damage markers in patients with pandemic influenza A (H1N1/09)
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Assessing the potential pandemic risk of recent avian influenza viruses
Source: Eur Respir J , 49 (3) 1602517; DOI: 10.1183/13993003.02517-2016
Year: 2017
Pneumonia and pandemic influenza virus A (H1N1/09). Immediate and remote results
Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic
Year: 2011
Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
The relation of people to vaccination against an influenza virus
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010
Arterial hypoxemia and diminished immune response at admission predict poor outcome in patients with viral-bacterial pneumonia during flu H1N1 pandemic period
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Avian influenza and SARS – how much of a threat is it to humans and what can be done to prevent this?
Source: Annual Congress 2005 - Major viral threats to the lung
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept